Epstein-Barr Virus Polymerase Processivity Factor Enhances BALF2 Promoter Transcription As a Coactivator for the BZLF1 Immediate-early Protein
Overview
Authors
Affiliations
The Epstein-Barr virus (EBV) BMRF1 protein is an essential replication protein acting at viral replication forks as a viral DNA polymerase processivity factor, whereas the BALF2 protein is a single-stranded DNA-binding protein that also acts at replication forks and is most abundantly expressed during viral productive replication. Here we document that the BMRF1 protein evidently enhances viral BZLF1 transcription factor-mediated transactivation of the BALF2 gene promoter. Mutagenesis and electrophoretic mobility shift assays demonstrated the BALF2 promoter to harbor two BZLF1 protein-binding sites (BZLF1-responsive elements). Direct binding of the BZLF1 protein to BZLF1-responsive elements and physical interaction between BZLF1 and BMRF1 proteins are prerequisite for the BMRF1 protein up-regulation of the BALF2 gene promoter. A monomeric mutant, C95E, which is defective in homodimerization, could still interact and enhance BZLF1-mediated transactivation. Furthermore although EBV protein kinase phosphorylates BMRF1 protein extensively, it turned out that phosphorylation of the protein by the kinase is inhibitory to the enhancement of the BZLF1-mediated transactivation of BALF2 promoter. Exogenous expression of BMRF1 protein augmented BALF2 expression in HEK293 cells harboring the EBV genome but lacking BMRF1 and BALF5 genes, demonstrating functions as a transcriptional regulator in the context of viral infection. Overall the BMRF1 protein is a multifunctional protein that cannot only act as a DNA polymerase processivity factor but also enhances BALF2 promoter transcription as a coactivator for the BZLF1 protein, regulating the expression level of viral single-stranded DNA-binding protein.
Argirion I, Pfeiffer R, Proietti C, Coghill A, Yu K, Middeldorp J Cancer Epidemiol Biomarkers Prev. 2023; 32(5):687-696.
PMID: 36788424 PMC: 10159936. DOI: 10.1158/1055-9965.EPI-22-0452.
Trompet E, Temblador A, Gillemot S, Topalis D, Snoeck R, Andrei G Viruses. 2021; 13(6).
PMID: 34073189 PMC: 8227558. DOI: 10.3390/v13060985.
Zhou Y, Heesom K, Osborn K, Almohammed R, Sweet S, Sinclair A J Virol. 2019; 94(3).
PMID: 31694936 PMC: 7000981. DOI: 10.1128/JVI.00927-19.
Salamun S, Sitz J, De La Cruz-Herrera C, Yockteng-Melgar J, Marcon E, Greenblatt J J Virol. 2019; 93(22).
PMID: 31462557 PMC: 6819917. DOI: 10.1128/JVI.01070-19.
BGLF2 Increases Infectivity of Epstein-Barr Virus by Activating AP-1 upon Infection.
Konishi N, Narita Y, Hijioka F, Masud H, Sato Y, Kimura H mSphere. 2018; 3(2).
PMID: 29695622 PMC: 5917423. DOI: 10.1128/mSphere.00138-18.